Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Ureteral Patency in the Post-indigo Carmine Era
NCT02677623Phase 4Completed
- Sponsor
- Columbia University
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenazopyridine, fluorescein and Bronchitol in ureteral injury, sponsored by Columbia University. Primary endpoint: Visual Analog Scale. Started Mar 2015; status: completed.
02
Drugs
phenazopyridinefluoresceinBronchitol
03
Conditions
ureteral injury
Beyond the preview
Go deeper on NCT02677623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677623.